While Invitrogen is making news merging into Applied Biosystems, with its $ 6.7 B USD deal creating the first of its kind of company, that can boast to own and invade every sphere of biological research from wet lab to information systems. Pfizer is planning to counter bid the $4.6 billion offer by Japan’s Daiichi [...]
Filed under: Biotech, Drug News, M&A, Pharmaceutical Company | 1 Comment »
